Barclays’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.35M | Buy |
262,725
+146,159
| +125% | +$2.97M | ﹤0.01% | 1568 |
|
|
2025
Q1 | $2.12M | Sell |
116,566
-26,348
| -18% | -$478K | ﹤0.01% | 1989 |
|
|
2024
Q4 | $3.61M | Buy |
142,914
+12,533
| +10% | +$317K | ﹤0.01% | 1825 |
|
|
2024
Q3 | $4.43M | Buy |
130,381
+76,207
| +141% | +$2.59M | ﹤0.01% | 1615 |
|
|
2024
Q2 | $2M | Sell |
54,174
-12,540
| -19% | -$464K | ﹤0.01% | 1701 |
|
|
2024
Q1 | $2.8M | Sell |
66,714
-79,180
| -54% | -$3.32M | ﹤0.01% | 1710 |
|
|
2023
Q4 | $5.79M | Buy |
145,894
+2,431
| +2% | +$96.4K | ﹤0.01% | 1382 |
|
|
2023
Q3 | $3.95M | Sell |
143,463
-28,671
| -17% | -$789K | ﹤0.01% | 1276 |
|
|
2023
Q2 | $5.84M | Buy |
172,134
+63,110
| +58% | +$2.14M | ﹤0.01% | 1147 |
|
|
2023
Q1 | $3.92M | Sell |
109,024
-7,447
| -6% | -$268K | ﹤0.01% | 1223 |
|
|
2022
Q4 | $5.19M | Sell |
116,471
-28,116
| -19% | -$1.25M | ﹤0.01% | 1086 |
|
|
2022
Q3 | $4.06M | Buy |
144,587
+47,500
| +49% | +$1.34M | ﹤0.01% | 1214 |
|
|
2022
Q2 | $2.62M | Sell |
97,087
-109,613
| -53% | -$2.96M | ﹤0.01% | 1408 |
|
|
2022
Q1 | $7.04M | Buy |
206,700
+66,748
| +48% | +$2.27M | 0.01% | 1009 |
|
|
2021
Q4 | $5.41M | Buy |
139,952
+100,184
| +252% | +$3.87M | ﹤0.01% | 1188 |
|
|
2021
Q3 | $2.15M | Buy |
39,768
+17,943
| +82% | +$969K | ﹤0.01% | 1821 |
|
|
2021
Q2 | $730K | Sell |
21,825
-33,474
| -61% | -$1.12M | ﹤0.01% | 2279 |
|
|
2021
Q1 | $1.14M | Buy |
55,299
+54,799
| +10,960% | +$1.13M | ﹤0.01% | 2223 |
|
|
2020
Q4 | $9K | Sell |
500
-366
| -42% | -$6.59K | ﹤0.01% | 3446 |
|
|
2020
Q3 | $13K | Buy |
866
+864
| +43,200% | +$13K | ﹤0.01% | 3538 |
|
|
2020
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3791 |
|
|
2019
Q4 | – | Sell |
-26
| Closed | – | – | 3894 |
|
|
2019
Q3 | $0 | Sell |
26
-3,900
| -99% | – | ﹤0.01% | 4143 |
|
|
2019
Q2 | $10K | Sell |
3,926
-5,200
| -57% | -$13.2K | ﹤0.01% | 4016 |
|
|
2019
Q1 | $45K | Buy |
9,126
+9,121
| +182,420% | +$45K | ﹤0.01% | 3691 |
|
|
2018
Q4 | $0 | Sell |
5
-463
| -99% | – | ﹤0.01% | 4119 |
|
|
2018
Q3 | $3K | Sell |
468
-11,316
| -96% | -$72.5K | ﹤0.01% | 4123 |
|
|
2018
Q2 | $89K | Buy |
11,784
+8,994
| +322% | +$67.9K | ﹤0.01% | 3110 |
|
|
2018
Q1 | $97K | Buy |
2,790
+1,399
| +101% | +$48.6K | ﹤0.01% | 3179 |
|
|
2017
Q4 | $59K | Buy |
1,391
+1,082
| +350% | +$45.9K | ﹤0.01% | 3277 |
|
|
2017
Q3 | $13K | Buy |
309
+238
| +335% | +$10K | ﹤0.01% | 3343 |
|
|
2017
Q2 | $2K | Sell |
71
-1,172
| -94% | -$33K | ﹤0.01% | 3675 |
|
|
2017
Q1 | $68K | Buy |
1,243
+632
| +103% | +$34.6K | ﹤0.01% | 2991 |
|
|
2016
Q4 | $32K | Buy |
611
+52
| +9% | +$2.72K | ﹤0.01% | 2965 |
|
|
2016
Q3 | $33K | Buy |
+559
| New | +$33K | ﹤0.01% | 2871 |
|
|
2016
Q2 | – | Sell |
-2,203
| Closed | -$99K | – | 3623 |
|
|
2016
Q1 | $99K | Sell |
2,203
-11,245
| -84% | -$505K | ﹤0.01% | 2326 |
|
|
2015
Q4 | $3.03M | Buy |
13,448
+11,592
| +625% | +$2.61M | ﹤0.01% | 894 |
|
|
2015
Q3 | $279K | Buy |
1,856
+1,526
| +462% | +$229K | ﹤0.01% | 1980 |
|
|
2015
Q2 | $124K | Buy |
330
+144
| +77% | +$54.1K | ﹤0.01% | 2273 |
|
|
2015
Q1 | $75K | Sell |
186
-2,713
| -94% | -$1.09M | ﹤0.01% | 2595 |
|
|
2014
Q4 | $783K | Sell |
2,899
-667
| -19% | -$180K | ﹤0.01% | 1753 |
|
|
2014
Q3 | $642K | Buy |
3,566
+361
| +11% | +$65K | ﹤0.01% | 1869 |
|
|
2014
Q2 | $769K | Sell |
3,205
-1,171
| -27% | -$281K | ﹤0.01% | 1821 |
|
|
2014
Q1 | $1.12M | Sell |
4,376
-4,436
| -50% | -$1.13M | ﹤0.01% | 1610 |
|
|
2013
Q4 | $3.17M | Buy |
8,812
+4,141
| +89% | +$1.49M | ﹤0.01% | 1181 |
|
|
2013
Q3 | $2.45M | Buy |
4,671
+3,883
| +493% | +$2.04M | ﹤0.01% | 1186 |
|
|
2013
Q2 | $184K | Buy |
+788
| New | +$184K | ﹤0.01% | 2732 |
|